Form 4 for JAZZ Jazz Pharmaceuticals plc
Accepted 2024-12-04 00:00:00 ET · period of report 2024-12-02 · accession 0001765581-24-000092 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-12-04 | 2024-12-02 | JAZZ | COZADD BRUCE C | COB, CEO, Dir | S - Sale | $121.17 | -2,000 | 427.0K | -0.5% | -$242.3K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2024-12-02 | S | D | 2,000 | $121.17 | 427,025 | D | — | — | (F2) The Reporting Person acquired 49 ordinary shares under a Section 423 Employee Stock Purchase Plan on November 29, 2024. |